Enverde Altifarm Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-06-2024
- Paid Up Capital ₹ 0.12 M
as on 25-06-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 9.80 M
as on 25-06-2024
- Revenue 849.23%
(FY 2021)
- Profit 148.15%
(FY 2021)
- Ebitda 202.68%
(FY 2021)
- Net Worth 92.90%
(FY 2021)
- Total Assets 103.80%
(FY 2021)
About Enverde Altifarm
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹9.80 M.
Praditha Muralidharan, Alexander Jacob, and Arun Raj serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC304377
- Company No.
304377
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Enverde Altifarm?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Raj  | Director | 18-Jan-2018 | Current |
| Praditha Muralidharan | Director | 15-Jun-2018 | Current |
| Alexander Jacob | Director | 31-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Enverde Altifarm.
Enverde Altifarm Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 849.23% increase. The company also saw a substantial improvement in profitability, with a 148.15% increase in profit. The company's net worth Soared by an impressive increase of 92.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enverde Altifarm?
In 2021, Enverde Altifarm had a promoter holding of 86.09% and a public holding of 13.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Sep 2018 | ₹9.80 M | Open |
How Many Employees Work at Enverde Altifarm?
Unlock and access historical data on people associated with Enverde Altifarm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enverde Altifarm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enverde Altifarm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
